TEVA-RIVAROXABAN

Identification of Teva-Rivaroxaban

No description

Google image searchProduct monograph

Active ingredient

rivaroxaban, 15 MG

DIN: 02507218

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 01-NOV-2023

ATC:

• B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
• B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
• B01AF — Direct factor Xa inhibitors (ATC, ATC/DDD)
• B01AF01 — RIVAROXABAN (ATC/DDD)

Reference brand drug: Xarelto

External Links for Teva-Rivaroxaban

Search on Google

• Teva-Rivaroxaban side effects
• Teva-Rivaroxaban dosage
• rivaroxaban side effects
• rivaroxaban dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-rivaroxaban photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.